Breaking News Instant updates and real-time market news.

2022-03-24 07:42:23 KHTRF Knight Therapeutics $4.19 / -0.26 (-5.84%) 07:42 03/24/22 03/24 07:42 03/24/22 07:42	Knight Therapeutics reports Q4 EPS (C$0.07) vs. C$0.6 last year Reports Q4 revenue C$58.27M vs. C$55.19M last year. "I am excited to announce that 2021 was a record-setting year in Knight's history, despite the ongoing challenges posed by the pandemic. During the year, we made significant strides towards completing the integration of the Grupo Biotoscana acquisition, all while strengthening the team and processes and driving strong performance. As part of our integration activities, we completed the implementation of several key systems including, a global CRM, HR IS and a global pharmacovigilance system. In addition, we implemented ERP for 14 legal entities in 6 countries. We further strengthened Knight's management team with the addition of a Global VP Commercial, a Global VP Scientific Affairs, a Global VP Legal and Compliance and a Global VP Human Resources and most recently added a VP Manufacturing and Operations, to continue delivering on growth and operational excellence. Our business development team closed the acquisition of Exelon and entered into an exclusive supply and distribution agreement with Incyte. Our regulatory team advanced our portfolio with the approval of Halaven, Lenvima and Rembre in Colombia as well as the approval of Nerlynx, while our commercial team continued to deliver on strong growth of our key brands. It is thanks to the hard work of our employees that we achieved unprecedented results in 2021 and we are entering 2022 with a stronger platform that is well equipped to continue delivering on further growth and success." said Samira Sakhia, President and CEO.

2022-03-24 07:42:23

KHTRF

Knight Therapeutics

$4.19 / -0.26 (-5.84%)

07:42

03/24/22

03/24

07:42

03/24/22

07:42

Knight Therapeutics reports Q4 EPS (C$0.07) vs. C$0.6 last year

Reports Q4 revenue C$58.27M vs. C$55.19M last year. "I am excited to announce that 2021 was a record-setting year in Knight's history, despite the ongoing challenges posed by the pandemic. During the year, we made significant strides towards completing the integration of the Grupo Biotoscana acquisition, all while strengthening the team and processes and driving strong performance. As part of our integration activities, we completed the implementation of several key systems including, a global CRM, HR IS and a global pharmacovigilance system. In addition, we implemented ERP for 14 legal entities in 6 countries. We further strengthened Knight's management team with the addition of a Global VP Commercial, a Global VP Scientific Affairs, a Global VP Legal and Compliance and a Global VP Human Resources and most recently added a VP Manufacturing and Operations, to continue delivering on growth and operational excellence. Our business development team closed the acquisition of Exelon and entered into an exclusive supply and distribution agreement with Incyte. Our regulatory team advanced our portfolio with the approval of Halaven, Lenvima and Rembre in Colombia as well as the approval of Nerlynx, while our commercial team continued to deliver on strong growth of our key brands. It is thanks to the hard work of our employees that we achieved unprecedented results in 2021 and we are entering 2022 with a stronger platform that is well equipped to continue delivering on further growth and success." said Samira Sakhia, President and CEO.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Vuzix reports follow-on smart glasses order valued at over $350,000 » 08:23 07/06/22 07/06 08:23 07/06/22 08:23 VUZI Vuzix $7.33 / +0.63 (+9.40%) Yesterday, Vuzix… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options VUZI Vuzix $7.33 / +0.63 (+9.40%) 05/19/22 Vuzix signs license agreements with Atomistic 05/10/22 Cathie Wood's ARK Investment bought 337.2K shares of Vuzix today 05/10/22 Vuzix CEO says Q2 outlook 'quite positive' 05/06/22 Vuzix receives multiple waveguide-based product reorders VUZI Vuzix $7.33 / +0.63 (+9.40%) 03/02/22 Craig-Hallum Vuzix price target lowered to $11 from $30 at Craig-Hallum 12/21/21 Dawson James Vuzix initiated with a Buy at Dawson James VUZI Vuzix $7.33 / +0.63 (+9.40%) 05/10/22 Vuzix reports Q1 EPS (16c), consensus (15c) 03/01/22 Vuzix reports Q4 EPS (27c), consensus (12c) VUZI Vuzix $7.33 / +0.63 (+9.40%) 04/14/22 Meet Vuzix: Fly exclusive interview with CEO Paul Travers VUZI Vuzix $7.33 / +0.63 (+9.40%) 06/28/22 Largest borrow rate increases among liquid names 06/24/22 Unusually active option classes on open June 24th 06/08/22 Largest borrow rate increases among liquid names 05/31/22 Largest borrow rate increases among liquid names
Hot Stocks	Norwegian Cruise Line to no longer require pre-cruise COVID-19 testing » 08:22 07/06/22 07/06 08:22 07/06/22 08:22 NCLH Norwegian Cruise Line $12.47 / +1.13 (+9.96%) Norwegian Cruise Line… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NCLH Norwegian Cruise Line $12.47 / +1.13 (+9.96%) 06/08/22 Norwegian Cruise Line releases 2021 ESG report 05/10/22 Norwegian Cruise Line expects to report a net loss for Q2 05/10/22 Norwegian Cruise Line taking 'proactive measures' to enhance liquidity 05/10/22 Norwegian Cruise Line: Current booked position for 2H below 2019 period NCLH Norwegian Cruise Line $12.47 / +1.13 (+9.96%) 06/29/22 Barclays Barclays initiates cruise line space with Royal Caribbean top pick 06/28/22 Barclays Norwegian Cruise Line initiated with an Equal Weight at Barclays 06/21/22 Deutsche Bank Norwegian Cruise Line price target lowered to $17 from $23 at Deutsche Bank 06/09/22 Susquehanna Norwegian Cruise Line initiated with a Positive at Susquehanna NCLH Norwegian Cruise Line $12.47 / +1.13 (+9.96%) 05/10/22 Norwegian Cruise Line reports Q1 adjusted EPS ($1.82), consensus ($1.53) 05/09/22 Notable companies reporting before tomorrow's open 05/09/22 Notable companies reporting before tomorrow's open 02/24/22 Norwegian Cruise Line reports Q4 EPS ($1.95), consensus ($1.60) NCLH Norwegian Cruise Line $12.47 / +1.13 (+9.96%) 07/02/22 Not the time to bottom-fish cruise operator stocks, Barron's says 05/02/22 Fincantieri, Norwegian in discussions over $4B cruise ship order, Reuters says 03/02/22 Carnival, Norwegian update mask policy, now optional for most, WSJ reports 01/07/22 Royal Caribbean, Norwegian Cruise cancel trips due to omicron, Reuters reports NCLH Norwegian Cruise Line $12.47 / +1.13 (+9.96%) 04/13/22 What You Missed On Wall Street On Wednesday 04/13/22 What You Missed On Wall Street This Morning 03/17/22 What You Missed On Wall Street On Thursday 03/17/22 What You Missed On Wall Street This Morning NCLH Norwegian Cruise Line $12.47 / +1.13 (+9.96%) 06/30/22 Unusually active option classes on open June 30th 06/27/22 Unusually active option classes on open June 27th 06/24/22 Norwegian Cruise Line call volume above normal and directionally bullish 06/24/22 Early notable gainers among liquid option names on June 24th
Hot Stocks	Sarepta's Duchenne muscular dystrophy candidate shows efficacy in studies » 08:22 07/06/22 07/06 08:22 07/06/22 08:22 SRPT Sarepta $75.70 / +0.01 (+0.01%) , RHHBY Roche $41.57 / -0.44 (-1.05%) Sarepta (SRPT) and its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events SRPT RHHBY SRPT Sarepta $75.70 / +0.01 (+0.01%) 06/23/22 Sarepta announces clinical hold placed on SRP-5051 trial by FDA 06/13/22 Selecta Biosciences announces partnership, clinical trial updates 04/20/22 Vigil Neuroscience appoints Christopher Verni as general counsel 04/14/22 Editas Medicine appoints Gilmore O'Neill as CEO RHHBY Roche $41.57 / -0.44 (-1.05%) 05:18 Today Genentech announces FDA acceptance of mosunetuzumab BLA 06/16/22 FTC says to ramp up enforcement against illegal drug rebate schemes 06/16/22 Roche launches human papillomavirus self-sampling solution 06/16/22 Roche says crenezumab did not slow decline in autosomal dominant Alzheimer's SRPT RHHBY SRPT Sarepta $75.70 / +0.01 (+0.01%) 07/05/22 Morgan Stanley Sarepta named a 'Catalyst Driven Idea' at Morgan Stanley ahead of 9001 update 06/24/22 Evercore ISI Sarepta clinical hold has 'no impact' on Evercore ISI's model 06/24/22 Cantor Fitzgerald Sarepta price target lowered to $128 from $140 at Cantor Fitzgerald 06/24/22 Credit Suisse Sarepta price target lowered to $90 from $95 at Credit Suisse RHHBY Roche $41.57 / -0.44 (-1.05%) 06/27/22 Cowen Roche price target lowered to $48 from $58 at Cowen 06/02/22 Piper Sandler Piper ups Repare Therapeutics target after 'great deal' with Roche 05/19/22 Credit Suisse Roche price target lowered to CHF 350 from CHF 370 at Credit Suisse 05/13/22 Jefferies Roche downgraded to Hold from Buy at Jefferies SRPT RHHBY SRPT Sarepta $75.70 / +0.01 (+0.01%) 05/04/22 Sarepta reports Q1 EPS ($1.20), consensus ($1.27) 03/01/22 Notable companies reporting after market close 01/10/22 Sarepta reports preliminary Q4 revenue $178.7M, consensus $197.25M RHHBY Roche $41.57 / -0.44 (-1.05%) 04/25/22 Roche reports Q1 group sales CHF 16.445B vs. CHF 14.93B last year 02/03/22 Roche sees FY22 core earnings growing in low- to mid-single digit range 02/03/22 Roche reports 2021 core EPS CHF 19.81 vs CHF 19.16 14 Oct RHHBY RHHBY Roche $41.57 / -0.44 (-1.05%) 02/24/22 Drugmakers criticize Medicare proposal on Biogen's Alzheimer's drug, WSJ says 02/09/22 Credit Suisse shareholders to block moves to extend Schwan's tenure, FT reports SRPT RHHBY SRPT Sarepta $75.70 / +0.01 (+0.01%) 06/24/22 Fly Intel: Pre-market Movers 06/23/22 Fly Intel: After-Hours Movers 05/31/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/01/22 Fly Intel: After-Hours Movers RHHBY Roche $41.57 / -0.44 (-1.05%) 06/02/22 What You Missed On Wall Street This Morning 01/13/22 Meet Prothena: Fly exclusive interview with CEO Gene Kinney 08/11/22 Biotech/Biopharma 07/21/22 RNA Therapeutics Virtual Summit 07/21/22 Roche - RHHBY
Hot Stocks	Jack Henry announces collaboration with LINKBANCORP » 08:22 07/06/22 07/06 08:22 07/06/22 08:22 JKHY Jack Henry $183.66 / -0.76 (-0.41%) Jack Henry &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options JKHY Jack Henry $183.66 / -0.76 (-0.41%) 05/19/22 Jack Henry & Associates, Array announce collaboration 05/04/22 Jack Henry names Renee Swearingen as Chief Accounting Officer 03/08/22 Jack Henry COO Adelson sells 4,400 common shares 02/14/22 Jack Henry raises dividend 7% to 49c JKHY Jack Henry $183.66 / -0.76 (-0.41%) 06/15/22 Morgan Stanley Jack Henry initiated with an Equal Weight at Morgan Stanley 03/01/22 Oppenheimer Jack Henry upgraded to Outperform from Perform at Oppenheimer 02/11/22 DA Davidson Jack Henry price target raised to $204 from $188 at DA Davidson 02/10/22 DA Davidson Jack Henry price target raised to $204 from $188 at DA Davidson JKHY Jack Henry $183.66 / -0.76 (-0.41%) 05/03/22 Jack Henry sees FY22 GAAP EPS $4.80-$4.85, consensus $4.81 05/03/22 Jack Henry reports Q3 EPS $1.16, consensus $1.06 02/08/22 Jack Henry sees FY22 GAAP EPS $4.75-$4.82, consensus $4.71 02/08/22 Jack Henry reports Q2 GAAP EPS $1.30, consensus $1.23 JKHY Jack Henry $183.66 / -0.76 (-0.41%) 06/15/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations JKHY Jack Henry $183.66 / -0.76 (-0.41%) 01/21/22 Early notable gainers among liquid option names on January 21st
Hot Stocks	DoorDash, Uber slide after Amazon strikes deal with Grubhub » 08:22 07/06/22 07/06 08:22 07/06/22 08:22 DASH DoorDash $74.90 / +7.07 (+10.42%) , UBER Uber $22.53 / +1.18 (+5.53%) , AMZN Amazon.com $113.56 / +3.995 (+3.65%) , TKAYY Just Eat Takeaway.com $10.47 / + (+0.00%) Shares of DoorDash (DASH)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options DASH UBER AMZN TKAYY DASH DoorDash $74.90 / +7.07 (+10.42%) 06/13/22 DoorDash launches new app features to 'rate, review and discover' 06/08/22 Uber debuts Nationwide shipping, enables 'cross-country cravings' from US cities 05/20/22 DoorDash discloses $400M share repurchase program 05/16/22 Lone Pine adds TSMC in Q1, exits KE Holdings and Adobe UBER Uber $22.53 / +1.18 (+5.53%) 07/01/22 Uber releases its second US safety report 06/28/22 Group of 34 companies ask California Governor to allow autonomous trucks 06/23/22 Uber CEO says 'zero truth' to Bloomberg report on Indian ride-hailing business 06/21/22 Uber announces availability of UberX Share carpooling AMZN Amazon.com $113.56 / +3.995 (+3.65%) 05:49 Today Amazon to take stake in Grubhub as part of Just Eat Takeaway.com agreement 05:48 Today Just Eat Takeaway.com, Amazon enter into commercial agreement in the U.S. 05:06 Today Amazon announces new deals for Prime members ahead of Prime Day 07/05/22 EU regulators adopt new rules to monitor 'Tech Giants' TKAYY Just Eat Takeaway.com $10.47 / + (+0.00%) 05:49 Today Amazon to take stake in Grubhub as part of Just Eat Takeaway.com agreement 05:48 Today Just Eat Takeaway.com continuing to explore sale of Grubhub 05:48 Today Just Eat Takeaway.com, Amazon enter into commercial agreement in the U.S. 06/27/22 Brinker, Grubhub to bring Chili's, It's Just Wings to Grubhub marketplace DASH UBER AMZN TKAYY DASH DoorDash $74.90 / +7.07 (+10.42%) 06/29/22 JPMorgan DoorDash price target lowered to $90 from $100 at JPMorgan 06/27/22 Needham DoorDash price target lowered to $100 from $140 at Needham 06/21/22 Goldman Sachs DoorDash reinstated with a Neutral at Goldman Sachs 06/06/22 Raymond James DoorDash initiated with a Market Perform at Raymond James UBER Uber $22.53 / +1.18 (+5.53%) 06/29/22 JPMorgan Uber price target lowered to $48 from $60 at JPMorgan 06/29/22 Wedbush Uber assumed with an Outperform at Wedbush 06/24/22 Wolfe Research Uber price target lowered to $27 from $30 at Wolfe Research 06/16/22 Mizuho Uber hits 'speed bump' in Massachusetts, says Mizuho AMZN Amazon.com $113.56 / +3.995 (+3.65%) 06/29/22 JPMorgan Amazon.com price target lowered to $175 from $200 at JPMorgan 06/29/22 Redburn Microsoft initiated with a Buy at Redburn 06/29/22 Redburn Amazon.com initiated with a Buy at Redburn 06/29/22 Wolfe Research Amazon.com price target lowered to $140 from $145 at Wolfe Research TKAYY Just Eat Takeaway.com $10.47 / + (+0.00%) 07/07/21 Bernstein Just Eat Takeaway.com initiated with an Outperform at Bernstein DASH UBER AMZN DASH DoorDash $74.90 / +7.07 (+10.42%) 05/05/22 DoorDash reports Q1 EPS (48c), consensus (41c) 05/05/22 Notable companies reporting after market close 02/16/22 DoorDash reports Q4 EPS (45c), consensus (25c) 02/16/22 Notable companies reporting after market close UBER Uber $22.53 / +1.18 (+5.53%) 05/04/22 Uber reports Q1 EPS ($3.04), consensus (24c) 02/09/22 Uber reports Q4 EPS 44c, consensus (35c) 02/09/22 Uber reports Q4 revenue $5.78B, consensus $5.34 02/09/22 Notable companies reporting after market close AMZN Amazon.com $113.56 / +3.995 (+3.65%) 05/05/22 AES Corp.to provide 450 MW of renewable energy to Amazon 04/28/22 Amazon sees Q2 revenue $116B-$121B, consensus $125.55B 04/28/22 Amazon reports Q1 EPS ($7.56) with Rivian expense, consensus $8.36 04/28/22 Notable companies reporting after market close 19 Aug 29 Jul DASH UBER AMZN DASH DoorDash $74.90 / +7.07 (+10.42%) 05/12/22 Instacart listing could happen as soon as this year, Bloomberg reports 03/23/22 Instacart plans to launch 15-minute grocery delivery service, Information says 03/17/22 Ride-hailing, delivery app drivers stretched amid spiking gas prices, NYT says 03/08/22 Uber, Lyft, others launch ad campaign to prevent unions, WSJ reports UBER Uber $22.53 / +1.18 (+5.53%) 06/29/22 Waymo, others call on CA to lift ban on heavy self-driving trucks, Verge says 06/29/22 Uber raises UAE fares due to surge in gas prices, Bloomberg reports 06/23/22 Uber explored options for Indian ride-hailing unit, Bloomberg reports 06/10/22 Uber's head of rides in U.S., Canada leaving company, Insider reports AMZN Amazon.com $113.56 / +3.995 (+3.65%) 05:45 Today Amazon to share more data with competitors after EU antitrust deal, FT reports 07/05/22 Amazon,Microsoft, Google keep firm grip on cloud computing space, WSJ says 06/30/22 Amazon, Rite Aid limit purchase of emergency contraceptives, AP reports 06/29/22 Amazon moves to restrict LGBTQ-related products in UAE, NY Times says DASH UBER AMZN DASH DoorDash $74.90 / +7.07 (+10.42%) 07/02/22 Opening Day: Ivanhoe Electric falls in debut after raising $169M in IPO 06/25/22 Opening Day: Golden Sun rises in debut as Ivanhoe Electric delays IPO 06/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/11/22 Opening Day: EV-focused Phoenix Motor drops in market debut UBER Uber $22.53 / +1.18 (+5.53%) 07/02/22 Opening Day: Ivanhoe Electric falls in debut after raising $169M in IPO 06/29/22 #SocialStocks: Pinterest taps former Google executive as CEO 06/29/22 What You Missed On Wall Street This Morning 06/25/22 Opening Day: Golden Sun rises in debut as Ivanhoe Electric delays IPO AMZN Amazon.com $113.56 / +3.995 (+3.65%) 07/05/22 What You Missed On Wall Street On Tuesday 07/02/22 Opening Day: Ivanhoe Electric falls in debut after raising $169M in IPO 06/29/22 What You Missed On Wall Street On Wednesday 06/29/22 #SocialStocks: Pinterest taps former Google executive as CEO 10/09/22 64th NABE Annual Meeting 07/13/22 Amazon.com - AMZN DASH UBER AMZN DASH DoorDash $74.90 / +7.07 (+10.42%) 06/01/22 DoorDash put volume heavy and directionally bearish 05/05/22 DoorDash options imply 13.1% move in share price post-earnings 05/05/22 Unusually active option classes on open May 5th 04/26/22 DoorDash put volume heavy and directionally bearish UBER Uber $22.53 / +1.18 (+5.53%) 06/15/22 Notable open interest changes for June 15th 05/05/22 Notable open interest changes for May 5th 05/04/22 Notable open interest changes for May 4th 04/26/22 Uber put volume heavy and directionally bearish AMZN Amazon.com $113.56 / +3.995 (+3.65%) 08:00 Today Amazon call buyer realizes 151% same-day gains 07/05/22 Notable open interest changes for July 5th 07/01/22 Notable open interest changes for July 1st 07/01/22 Amazon call buyer realizes 68% same-day gains
Hot Stocks	IBM announces it acquired Databand.ai » 08:21 07/06/22 07/06 08:21 07/06/22 08:21 IBM IBM $137.63 / -3.505 (-2.48%) IBM announced it has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options IBM IBM $137.63 / -3.505 (-2.48%) 06/28/22 IBM says coverage for reproductive health services will continue 06/07/22 IBM announces 'orderly wind-down' of business in Russia 06/06/22 IBM plans to acquire Randori, terms not disclosed 06/03/22 Kyndryl says indemnity obligation potentially owed to IBM 'indeterminate' IBM IBM $137.63 / -3.505 (-2.48%) 06/27/22 Northland Telos price target raised to $11 at Northland after Xacta checks 05/18/22 Jefferies Information Technology sector upgraded to Bullish at Jefferies 04/20/22 BMO Capital IBM price target raised to $152 from $148 at BMO Capital 04/20/22 BofA IBM price target raised to $165 from $162 at BofA IBM IBM $137.63 / -3.505 (-2.48%) 04/19/22 IBM sees FY22 revenue growth at high end of mid-single digit range 04/19/22 IBM reports Q1 adjusted EPS $1.40, consensus $1.38 04/19/22 Notable companies reporting after market close 01/24/22 IBM CEO confident in 'mid-single digit revenue growth' in 2022 IBM IBM $137.63 / -3.505 (-2.48%) 06/07/22 IBM winding down business in Russia, Reuters reports 06/06/22 CFOs send letter to Treasury Secretary on foreign tax credit rules, WSJ reports 05/31/22 IBM ordered to pay BMC Software $1.6B over software swap, Bloomberg reports 05/31/22 IBM ordered to pay $1.6B in BMC Software case, Bloomberg reports IBM IBM $137.63 / -3.505 (-2.48%) 06/07/22 What You Missed On Wall Street On Tuesday 06/07/22 What You Missed On Wall Street This Morning 04/20/22 What You Missed On Wall Street On Wednesday 04/20/22 What You Missed On Wall Street This Morning 07/12/22 SEMICon West 2022 07/18/22 IBM - IBM IBM IBM $137.63 / -3.505 (-2.48%) 06/17/22 IBM put volume heavy and directionally bearish 04/20/22 Early notable gainers among liquid option names on April 20th 04/19/22 IBM options imply 4.1% move in share price post-earnings 04/14/22 IBM call volume above normal and directionally bullish
Earnings	Rail Vision reports Q1 EPS (26c) vs. (32c) last year » 08:21 07/06/22 07/06 08:21 07/06/22 08:21 RVSN Rail Vision / + Reports Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly RVSN Rail Vision / + 06/01/22 Rail Vision receives Japanese patent allowance for railway obstacle detection RVSN Rail Vision / + 05/02/22 Aegis Rail Vision initiated with a Buy at Aegis RVSN Rail Vision / + 04/02/22 Opening Day: Rail Vision, Expion360 come to market in another slow week
Hot Stocks	Immutep granted Japanese patent for IMP761 » 08:19 07/06/22 07/06 08:19 07/06/22 08:19 IMMP Immutep $2.16 / +0.125 (+6.16%) Immutep is pleased to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events IMMP Immutep $2.16 / +0.125 (+6.16%) 06/03/22 Immutep announces new data from 1st line NSCLC patients in TACTI-002 trial 05/27/22 Immutep publishes abstracts on TACTI-002, TACTI-003 05/18/22 Immutep appoints oncologists to its CAB 05/04/22 Immutep presents new data from AIPAC study IMMP Immutep $2.16 / +0.125 (+6.16%) 12/02/21 Jefferies Immutep initiated with a Buy at Jefferies 08/03/21 Ladenburg Ladenburg starts Immutep with Buy into 'value-driving' events 08/03/21 Ladenburg Immutep initiated with a Buy at Ladenburg 07/16/21 Maxim Immutep assumed with a Buy at Maxim 06/08/22 Global Healthcare Conference
Hot Stocks	Ovintiv to sell portions of its Uinta, Bakken assets for $250M » 08:19 07/06/22 07/06 08:19 07/06/22 08:19 OVV Ovintiv $39.91 / -3.58 (-8.23%) Ovintiv announced it has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options OVV Ovintiv $39.91 / -3.58 (-8.23%) 06/05/22 Fly Intel: Top five weekend stock stories 05/16/22 Third Point lowers stakes in Amazon, Intuit, exits Alphabet position 05/09/22 Ovintiv increases quarterly dividend 25% 02/24/22 Ovintiv sees Q1 capital investments $425M-$440M OVV Ovintiv $39.91 / -3.58 (-8.23%) 06/28/22 JPMorgan Ovintiv upgraded to Overweight from Neutral at JPMorgan 06/16/22 National Bank Ovintiv price target raised to $115 from $90 at National Bank 06/14/22 Barclays Ovintiv price target raised to $72 from $56 at Barclays 05/31/22 Mizuho Ovintiv price target lowered to $77 from $78 at Mizuho OVV Ovintiv $39.91 / -3.58 (-8.23%) 02/24/22 Ovintiv sees FY22 capital investment $1.5B 02/24/22 Ovintiv reports Q4 EPS $5.21, may not compare to consensus $1.64 OVV Ovintiv $39.91 / -3.58 (-8.23%) 06/04/22 Callon, Murphy Oil could benefit if oil keeps rising, Barron's says OVV Ovintiv $39.91 / -3.58 (-8.23%) 03/23/22 What You Missed On Wall Street On Wednesday 03/23/22 What You Missed On Wall Street This Morning OVV Ovintiv $39.91 / -3.58 (-8.23%) 04/01/22 Ovintiv put volume heavy and directionally bearish 02/11/22 Ovintiv put volume heavy and directionally bearish
Hot Stocks	Poet announces sampling of 200G FR4 Transmit, Receive Optical Engines » 08:18 07/06/22 07/06 08:18 07/06/22 08:18 POETF Poet Technologies / + POET Technologies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News POETF Poet Technologies / + 03/03/22 Poet Technologies launches 400G FR4, 800G Receive Optical Engines 03/01/22 Poet Technologies announces product demos, tech showcase event 02/24/22 Poet Technologies, Liobate collaborate on photonic integrated circuits 02/22/22 Poet advances toward Nasdaq listing with 10-for-1 share consolidation

Hot Stocks	NextDecade executes 20-year SPA with Guangdong Energy » 08:17 07/06/22 07/06 08:17 07/06/22 08:17 NEXT NextDecade $4.62 / +0.205 (+4.65%) NextDecade announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly NEXT NextDecade $4.62 / +0.205 (+4.65%) 07/05/22 NextDecade announces 1.0 MTPA LNG sale and purchase agreement With China Gas 06/08/22 NextDecade announces departure of COO Ivan Van der Walt 05/02/22 NextDecade executes 15-year SPA with Engie 04/06/22 NextDecade executes 20-year SPA with ENN LNG NEXT NextDecade $4.62 / +0.205 (+4.65%) 05/02/22 Stifel Stifel ticks up NextDecade target but still sees 'substantial risk' 04/26/22 Stifel NextDecade downgraded to Sell from Hold at Stifel 04/01/22 Credit Suisse NextDecade downgraded to Neutral from Outperform at Credit Suisse NEXT NextDecade $4.62 / +0.205 (+4.65%) 04/26/22 What You Missed On Wall Street On Tuesday 04/26/22 What You Missed On Wall Street This Morning 04/26/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/06/22 What You Missed On Wall Street On Wednesday
Hot Stocks	Cerberus Cyber completes acquisition of CyberViking » 08:17 07/06/22 07/06 08:17 07/06/22 08:17 CISO Cerberus Cyber $3.75 / +0.1 (+2.74%) Cerberus Cyber has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Syndicate Options CISO Cerberus Cyber $3.75 / +0.1 (+2.74%) 06/15/22 Cerberus Cyber set to join Russell 2000 Index 06/02/22 Cerberus Cyber completes acquisition of Creatrix 03/28/22 Cerberus Cyber elects Devoto to board of directors 03/21/22 Cerberus Cyber appoints Ashley Devoto as CISO 14 Jan CISO Cerberus Cyber $3.75 / +0.1 (+2.74%) 03/11/22 Three new option listings and one option delisting on March 11th
Recommendations	GreenPower Motor price target lowered to $9 from $14 at Maxim » 08:16 07/06/22 07/06 08:16 07/06/22 08:16 GP GreenPower Motor $3.44 / +0.29 (+9.21%) Maxim analyst Tate… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events GP GreenPower Motor $3.44 / +0.29 (+9.21%) 05/23/22 GreenPower Motor subsidiary announces joint venture with Jupiter Wagon Group 03/24/22 GreenPower Motor's vehicles eligible for up to $375,000 in California HVIP Funds 03/14/22 GreenPower Motor appoints RWC Group as a dealer for BEAST school bus 03/01/22 Workhorse Group, GreenPower Motor sign multi-year supply agreement GP GreenPower Motor $3.44 / +0.29 (+9.21%) 03/02/22 Roth Capital Roth upgrades Workhorse Group to Buy after 'substantial operating progress' 02/15/22 Roth Capital Roth Capital upgrades GreenPower Motor to Buy with $13 price target 02/15/22 Roth Capital GreenPower Motor upgraded to Buy from Neutral at Roth Capital 02/10/22 Maxim GreenPower Motor price target lowered to $14 from $22 at Maxim GP GreenPower Motor $3.44 / +0.29 (+9.21%) 02/11/22 GreenPower Motor reports Q3 revenue $5.31M, up 121.5% over $2.40M a year ago GP GreenPower Motor $3.44 / +0.29 (+9.21%) 03/07/22 What You May Have Missed This Week in EVs and Clean Energy 03/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/15/22 What You Missed On Wall Street On Tuesday 02/15/22 What You Missed On Wall Street This Morning 07/08/22 GreenPower Motor - GP
Hot Stocks	Dynatronics: CEO Krier to resume CFO role, Mike Withers joins as CIO » 08:16 07/06/22 07/06 08:16 07/06/22 08:16 DYNT Dynatronics / + Dynatronics Corporation… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings DYNT Dynatronics / + 01/19/22 Dynatronics announces Brian Baker rejoins as COO DYNT Dynatronics / + 05/12/22 Dynatronics sees 2022 revenue $44M-$45M 05/12/22 Dynatronics reports Q3 EPS (9c) vs. (0c) last year
Hot Stocks	NextCure reports publication supporting development of cancer candidate NC318 » 08:16 07/06/22 07/06 08:16 07/06/22 08:16 NXTC NextCure $4.62 / +0.115 (+2.55%) NextCure announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research NXTC NextCure $4.62 / +0.115 (+2.55%) 06/27/22 NextCure's NC410 data show enhanced immune cell infiltration, tumor reduction 06/22/22 NextCure appoints Brahm Segal to SAB, shares nonclinical data on NC410 04/19/22 NextCure, NCI announce preclinical data in Journal of Clinical Investigation NXTC NextCure $4.62 / +0.115 (+2.55%) 05/23/22 Piper Sandler NextCure price target lowered to $13 from $21 at Piper Sandler 03/01/22 Ladenburg NextCure initiated with Buy, $16 price target at Ladenburg 03/01/22 Ladenburg NextCure initiated with a Buy at Ladenburg 11/05/21 Piper Sandler NextCure's Phase II NC318 study continuing weekly dosing, says Piper Sandler
Hot Stocks	Bebuzee to file RegA next week » 08:16 07/06/22 07/06 08:16 07/06/22 08:16 ENGA Engage Technologies, Inc. / + The executive management… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News ENGA Engage Technologies, Inc. / + 06/08/22 Bebuzee to launch 'Shortbuz' inside Super App in coming months 05/04/22 Bebuzee to launch 'Properbuz' inside Super App in coming months 04/19/22 Bebuzee opens new offices in Miami in anticipation of launch of its 'Super App' 04/14/22 Bebuzee announces private placement offering up to $10M of common stock
Hot Stocks	Coherus, Junshi announces FDA acceptance of resubmission of Toripalimab BLA » 08:15 07/06/22 07/06 08:15 07/06/22 08:15 CHRS Coherus Biosciences $8.55 / +0.72 (+9.20%) Shanghai Junshi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CHRS Coherus Biosciences $8.55 / +0.72 (+9.20%) 05/05/22 Coherus Biosciences appoints Charlie Newton to board of directors 05/02/22 Coherus Biosciences, Junshi receive CRL for toripalimab BLA 05/02/22 Coherus, Junshi say CRL for toripalimab BLA requests quality process change 04/14/22 Coherus Biosciences, Junshi announce orphan drug designation for toripalimab CHRS Coherus Biosciences $8.55 / +0.72 (+9.20%) 06/13/22 UBS Coherus Biosciences initiated with a Neutral at UBS 06/13/22 UBS Coherus Biosciences initiated with a Neutral at UBS 05/20/22 Mizuho Coherus Biosciences price target lowered to $25 from $30 at Mizuho 05/09/22 Barclays Coherus Biosciences price target lowered to $15 from $20 at Barclays CHRS Coherus Biosciences $8.55 / +0.72 (+9.20%) 05/05/22 Coherus Biosciences reports Q1 EPS ($1.00), consensus (48c) 02/17/22 Coherus Biosciences reports Q4 EPS (46c), consensus (51c)
Downgrade	Evolution Petroleum downgraded to Neutral from Buy at Roth Capital » 08:15 07/06/22 07/06 08:15 07/06/22 08:15 EPM Evolution Petroleum $5.05 / -0.45 (-8.18%) Roth Capital analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News EPM Evolution Petroleum $5.05 / -0.45 (-8.18%) 07/05/22 Evolution Petroleum CEO Jason Brown to leave company 02/09/22 Evolution Petroleum acquires natural gas assets in Wyoming for $29.4M 01/20/22 Evolution Petroleum acquires non-operated assets in Williston Basin for $25.9M
Initiation	Aclarion initiated with a Buy at Maxim » 08:14 07/06/22 07/06 08:14 07/06/22 08:14 ACON Aclarion / + Maxim analyst Anthony… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate ACON Aclarion / + 06/22/22 Aclarion to present two-year follow up data on Nociscan clinical trial ACON Aclarion / + 07:42 Today Maxim Aclarion initiated with a Buy at Maxim 22 Apr
Hot Stocks	Farmmi announces new international order » 08:14 07/06/22 07/06 08:14 07/06/22 08:14 FAMI Farmmi $1.08 / +0.015 (+1.42%) Farmmi announced a new… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News FAMI Farmmi $1.08 / +0.015 (+1.42%) 06/23/22 Farmmi regains compliance with NASDAQ minimum bid price requirement 05/27/22 Farmmi appeals Nasdaq delisting determination 05/27/22 Farmmi announces 1-for-25 ordinary share consolidation 05/23/22 Farmmi to appeal Nasdaq delisting determination

Hot Stocks	Spire Marketing to provide RSG through agreement with Ascent Resources » 08:13 07/06/22 07/06 08:13 07/06/22 08:13 SR Spire $72.33 / -3.94 (-5.17%) Spire Marketing has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings SR Spire $72.33 / -3.94 (-5.17%) 02/02/22 Spire sees FY22 CapEx $570M SR Spire $72.33 / -3.94 (-5.17%) 05/25/22 Mizuho Spire price target raised to $77 from $74 at Mizuho 04/29/22 Mizuho Spire price target raised to $74 from $68 at Mizuho 04/19/22 Wells Fargo Spire price target raised to $81 from $70 at Wells Fargo 04/18/22 BofA Spire upgraded to Neutral from Underperform at BofA SR Spire $72.33 / -3.94 (-5.17%) 05/06/22 Spire narrows FY22 EPS view to $3.75-$3.95 from $3.70-$4.00, consensus $3.96 05/06/22 Spire reports Q2 EPS $3.42, consensus $3.11 02/02/22 Spire backs FY22 EPS view $3.70-$4.00, consensus $3.93 02/02/22 Spire reports Q1 EPS $1.14, consensus $1.32
Hot Stocks	Eyenovia partner enrolls first patient in Phase 3 trial of presbyopia candidate » 08:12 07/06/22 07/06 08:12 07/06/22 08:12 EYEN Eyenovia $1.85 / -0.06 (-3.14%) Eyenovia's strategic… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings EYEN Eyenovia $1.85 / -0.06 (-3.14%) 06/07/22 Eyenovia announces planned CEO transition 04/19/22 Eyenovia presents at American Sociey of Cataract and Refractive Surgery meeting 03/15/22 Eyenovia announces study results on Optejet 03/04/22 Eyenovia announces $15M investment from Armistice Capital Master Fund EYEN Eyenovia $1.85 / -0.06 (-3.14%) 10/26/21 Northland Eyenovia price target lowered to $9 from $12 at Northland EYEN Eyenovia $1.85 / -0.06 (-3.14%) 03/28/22 Eyenovia reports Q4 EPS 10c, vs. (17c) last year
Downgrade	Alexco Resource downgraded to Neutral from Buy at Roth Capital » 08:12 07/06/22 07/06 08:12 07/06/22 08:12 AXU Alexco Resource / + Roth Capital analyst Joe… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly AXU Alexco Resource / + 07/05/22 Hecla Mining to acquire Alexco Resource for 47c per share 07/05/22 Wheaton enters pact with Hecla Mining to terminate Keno Hill silver stream 07/05/22 Hecla Mining to acquire Alexco Resource for 47c per common share 03/21/22 Alexco Resource sees Q1 silver production 75,000-100,000 ounces AXU Alexco Resource / + 07:03 Today Alliance Global Partners Alexco Resource downgraded to Neutral from Buy at Alliance Global Partners 06/22/22 Cantor Fitzgerald Alexco Resource downgraded to Speculative Buy from Buy at Cantor Fitzgerald 06/22/22 Alliance Global Partners Alexco Resource price target lowered to $1.75 from $3.25 at Alliance Global Partners 10/29/21 Canaccord Alexco Resource upgraded to Speculative Buy from Hold at Canaccord AXU Alexco Resource / + 03/21/22 Alexco Resource reports Q4 adjusted EPS (C$0.04) vs. (C$0.07) a year ago AXU Alexco Resource / + 07/05/22 What You Missed On Wall Street On Tuesday 07/05/22 What You Missed On Wall Street This Morning 07/05/22 Fly Intel: Pre-market Movers
Hot Stocks	Catalyst Biosciences says court denies JDS1's motion for expedited proceedings » 08:12 07/06/22 07/06 08:12 07/06/22 08:12 CBIO Catalyst Biosciences $1.77 / -0.015 (-0.84%) Catalyst Biosciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options CBIO Catalyst Biosciences $1.77 / -0.015 (-0.84%) 06/29/22 Catalyst announces plan to distribute as much as $65M to stockholders 05/23/22 Catalyst Biosciences sells complement portfolio for $60M 03/15/22 Catalyst Biosciences regains full rights to CB 2782-PEG 02/17/22 Catalyst engages Perella Weinberg to assist in exploring strategic alternatives CBIO Catalyst Biosciences $1.77 / -0.015 (-0.84%) 05/23/22 Piper Sandler Piper Sandler remains bullish on Catalyst after sale of complement portfolio 03/31/22 Piper Sandler Piper says 'stick it out' with Catalyst Biosciences exploring options 11/12/21 JonesTrading Catalyst Biosciences downgraded to Hold from Buy at JonesTrading 11/12/21 Piper Sandler Catalyst Biosciences price target lowered to $4 from $16 at Piper Sandler CBIO Catalyst Biosciences $1.77 / -0.015 (-0.84%) 05/09/22 Catalyst Biosciences reports Q1 EPS (46c), consensus (44c) 03/31/22 Catalyst Biosciences reports Q4 EPS (65c), consensus (59c) CBIO Catalyst Biosciences $1.77 / -0.015 (-0.84%) 05/09/22 What You Missed On Wall Street This Morning CBIO Catalyst Biosciences $1.77 / -0.015 (-0.84%) 07/01/22 Unusually active option classes on open July 1st 05/23/22 Unusually active option classes on open May 23rd
Periodicals	Kuo: Apple's A16 processor to be exclusive to iPhone 14 Pro, AppleInsider says » 08:11 07/06/22 07/06 08:11 07/06/22 08:11 AAPL Apple $141.60 / +2.785 (+2.01%) Apple is expected to make… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AAPL Apple $141.60 / +2.785 (+2.01%) 07/05/22 EU regulators adopt new rules to monitor 'Tech Giants' 07/04/22 Fly Intel: Top five weekend stock stories 06/30/22 Apple's former director of corporate law admits to insider trading 06/30/22 Comcast's Xfinity Stream app launches on Apple TV 4K, Apple TV HD AAPL Apple $141.60 / +2.785 (+2.01%) 07/05/22 Morgan Stanley Apple App Store revenue grew 5% in June quarter, says Morgan Stanley 07/01/22 JPMorgan Apple near-term estimates 'resilient' despite concerns, says JPMorgan 06/30/22 Tigress Financial Tigress Financial reiterates Strong Buy on Apple, sees further upside in shares 06/30/22 Morgan Stanley Morgan Stanley Asia checks 'mostly validate' Qualcomm-Apple baseband chatter AAPL Apple $141.60 / +2.785 (+2.01%) 04/28/22 Apple says y/y Q3 revenue growth to be impacted by COVID 04/28/22 Apple reports Q2 EPS $1.52, consensus $1.43 04/28/22 Notable companies reporting after market close 02/27/22 Berkshire operating earnings surge, Buffett repurchases record $27B in stock AAPL Apple $141.60 / +2.785 (+2.01%) 06:17 Today Meta Platforms to continue its digital collectibles plan, FT reports 07/01/22 Apple raises price of iPhone in Japan, Reuters reports 06/28/22 Qualcomm to remain supplier for Apple's 2023 iPhones, MacRumors reports 06/27/22 Supreme Court passes on Apple, Qualcomm patent dispute, Bloomberg says AAPL Apple $141.60 / +2.785 (+2.01%) 07/05/22 What You Missed On Wall Street On Tuesday 07/01/22 What You Missed On Wall Street On Friday 07/01/22 What You Missed On Wall Street This Morning 06/28/22 What You Missed On Wall Street On Tuesday 07/28/22 Apple - AAPL AAPL Apple $141.60 / +2.785 (+2.01%) 06/30/22 Notable open interest changes for June 30th 06/29/22 Notable open interest changes for June 29th 06/29/22 Apple put buyer realizes 93% same-day gains 06/28/22 Notable open interest changes for June 28th

Events

Earnings calls, analyst events, roadshows and more

ASPU
Today at 09:30

Aspen Group, Inc. Firm Sponsored Meetings

276 Fifth Avenue, Suite 505, New York, NY
Today at 09:45

PMI Composite Final Serivces Index: June 2022 Government Event
Today at 10:00

ISM Services Index: June 2022 Government Event
Today at 10:00

Job Openings and Labor Turnover Survey: May 2022 Government Event
SABS
Today at 10:00

SAB Biotherapeutics Inc Firm Sponsored Meetings
HIL
Today at 10:00

Hill International, Inc. Firm Sponsored Meetings

2005 Market St Fl 17, Philadelphia, PA
NTUS
Today at 10:00

Natus Medical, Inc. Firm Sponsored Meetings
Today at 10:00

Biotech Industry Meetings
Today at 10:00

Financial Industry Meetings
NG
Today at 11:00

NovaGold - NG Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Knight Therapeutics reports Q4 EPS (C$0.07) vs. C$0.6 last year

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access